http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-289469-A5
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bfedd8ba4800708cecfd357707f8f67 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate | 1989-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbaf698d6138b8e8b45e227ba753801c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d8c620cc77274476f82d586b7c3ee87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2340b1d9fa51f2c26e415e1215e2c12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43859861c4b3a4802fb31833ecc34bd1 |
| publicationDate | 1991-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DD-289469-A5 |
| titleOfInvention | PROCESS FOR PREPARING LIPOSOME BASED PHARMACEUTICAL PREPARATIONS WITH ANTITUMORO GLYCOPEPTIDES AS ACTIVE COMPONENTS |
| abstract | The invention relates to a process for the preparation of pharmaceutical preparations based on liposomes with antitumor glycopeptides as active components. Liposome dispersions from these components show an enhanced antitumor effect compared to the free glycopeptide. Field of application is medicine or the pharmaceutical industry. The method according to the invention is characterized in that between basic substituents of the antitumor glycopeptides and acidic groups in the amphiphilic interactions used for vesicle formation. As a result, a substantial binding of the active ingredients to the liposomes is achieved. The inventive pharmaceutical preparations are characterized by relatively uniform size (50-200 nm) and high storage stability. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101199866-B |
| priorityDate | 1989-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.